Double-lung transplantation associated with lower mortality in IPF
1. Double-lung transplant is associated with lower 5-year mortality rates than single-lung transplant in patients with idiopathic pulmonary fibrosis (IPF). ...
1. Double-lung transplant is associated with lower 5-year mortality rates than single-lung transplant in patients with idiopathic pulmonary fibrosis (IPF). ...
1. Individuals with the healthiest overall diets according to the Alternate Health Eating Index 2010 (AHEI-2010) had the lowest risk ...
1. For patients admitted with chronic obstructive pulmonary disease (COPD) exacerbations requiring ventilatory support, non-invasive ventilation (NIV) was associated with ...
1. Compared to the use of long-acting β-agonists (LABAs) alone, combination therapy with LABAs and inhaled steroids resulted in a ...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Angiotensin–Neprilysin ...
1. A paradoxical response to beta-2 (β2)-agonists (causing bronchoconstriction rather than bronchodilation) was seen in 5% of former and current ...
1. Patients treated with benralizumab did not experience a reduced annual rate of acute COPD exacerbations. 2. However, benralizumab treatment ...
1. The combination of salmeterol and fluticasone did not significantly reduce all-cause mortality in patients with chronic pulmonary obstructive disease ...
Image: PD 1. Lung-volume-reduction surgery significantly improves exercise capacity, but not overall survival, in patients with emphysema when compared with ...
Image: PD 1. In a population based study of older adults, COPD was associated with an almost two-fold increased risk ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.